NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017

David Adelstein, Maura L. Gillison, David G. Pfister, Sharon Spencer, Douglas Adkins, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Moon Fenton, Robert L. Foote, Jill Gilbert, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra LeizmanWilliam M. Lydiatt, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Matthew Witek, Frank Worden, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan D. Darlow

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.

Original languageEnglish (US)
Pages (from-to)761-770
Number of pages10
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume15
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Head and Neck Neoplasms
Lip Neoplasms
Guidelines
Ethmoid Sinus
Oropharyngeal Neoplasms
Maxillary Sinus
Mouth Neoplasms
Proxy
Larynx
Pharynx
Salivary Glands
Practice Guidelines
Immunotherapy
Mouth
Neoplasms
Neck
Head
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Adelstein, D., Gillison, M. L., Pfister, D. G., Spencer, S., Adkins, D., Brizel, D. M., ... Darlow, S. D. (2017). NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN, 15(6), 761-770. https://doi.org/10.6004/jnccn.2017.0101

NCCN Guidelines Insights : Head and Neck Cancers, Version 2.2017. / Adelstein, David; Gillison, Maura L.; Pfister, David G.; Spencer, Sharon; Adkins, Douglas; Brizel, David M.; Burtness, Barbara; Busse, Paul M.; Caudell, Jimmy J.; Cmelak, Anthony J.; Colevas, A. Dimitrios; Eisele, David W.; Fenton, Moon; Foote, Robert L.; Gilbert, Jill; Haddad, Robert I.; Hicks, Wesley L.; Hitchcock, Ying J.; Jimeno, Antonio; Leizman, Debra; Lydiatt, William M.; Maghami, Ellie; Mell, Loren K.; Mittal, Bharat B.; Pinto, Harlan A.; Ridge, John A.; Rocco, James; Rodriguez, Cristina P.; Shah, Jatin P.; Weber, Randal S.; Witek, Matthew; Worden, Frank; Yom, Sue S.; Zhen, Weining; Burns, Jennifer L.; Darlow, Susan D.

In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 15, No. 6, 01.06.2017, p. 761-770.

Research output: Contribution to journalArticle

Adelstein, D, Gillison, ML, Pfister, DG, Spencer, S, Adkins, D, Brizel, DM, Burtness, B, Busse, PM, Caudell, JJ, Cmelak, AJ, Colevas, AD, Eisele, DW, Fenton, M, Foote, RL, Gilbert, J, Haddad, RI, Hicks, WL, Hitchcock, YJ, Jimeno, A, Leizman, D, Lydiatt, WM, Maghami, E, Mell, LK, Mittal, BB, Pinto, HA, Ridge, JA, Rocco, J, Rodriguez, CP, Shah, JP, Weber, RS, Witek, M, Worden, F, Yom, SS, Zhen, W, Burns, JL & Darlow, SD 2017, 'NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 15, no. 6, pp. 761-770. https://doi.org/10.6004/jnccn.2017.0101
Adelstein, David ; Gillison, Maura L. ; Pfister, David G. ; Spencer, Sharon ; Adkins, Douglas ; Brizel, David M. ; Burtness, Barbara ; Busse, Paul M. ; Caudell, Jimmy J. ; Cmelak, Anthony J. ; Colevas, A. Dimitrios ; Eisele, David W. ; Fenton, Moon ; Foote, Robert L. ; Gilbert, Jill ; Haddad, Robert I. ; Hicks, Wesley L. ; Hitchcock, Ying J. ; Jimeno, Antonio ; Leizman, Debra ; Lydiatt, William M. ; Maghami, Ellie ; Mell, Loren K. ; Mittal, Bharat B. ; Pinto, Harlan A. ; Ridge, John A. ; Rocco, James ; Rodriguez, Cristina P. ; Shah, Jatin P. ; Weber, Randal S. ; Witek, Matthew ; Worden, Frank ; Yom, Sue S. ; Zhen, Weining ; Burns, Jennifer L. ; Darlow, Susan D. / NCCN Guidelines Insights : Head and Neck Cancers, Version 2.2017. In: Journal of the National Comprehensive Cancer Network : JNCCN. 2017 ; Vol. 15, No. 6. pp. 761-770.
@article{d92c16e401e74743a78b5628d27ad846,
title = "NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017",
abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.",
author = "David Adelstein and Gillison, {Maura L.} and Pfister, {David G.} and Sharon Spencer and Douglas Adkins and Brizel, {David M.} and Barbara Burtness and Busse, {Paul M.} and Caudell, {Jimmy J.} and Cmelak, {Anthony J.} and Colevas, {A. Dimitrios} and Eisele, {David W.} and Moon Fenton and Foote, {Robert L.} and Jill Gilbert and Haddad, {Robert I.} and Hicks, {Wesley L.} and Hitchcock, {Ying J.} and Antonio Jimeno and Debra Leizman and Lydiatt, {William M.} and Ellie Maghami and Mell, {Loren K.} and Mittal, {Bharat B.} and Pinto, {Harlan A.} and Ridge, {John A.} and James Rocco and Rodriguez, {Cristina P.} and Shah, {Jatin P.} and Weber, {Randal S.} and Matthew Witek and Frank Worden and Yom, {Sue S.} and Weining Zhen and Burns, {Jennifer L.} and Darlow, {Susan D.}",
year = "2017",
month = "6",
day = "1",
doi = "10.6004/jnccn.2017.0101",
language = "English (US)",
volume = "15",
pages = "761--770",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - NCCN Guidelines Insights

T2 - Head and Neck Cancers, Version 2.2017

AU - Adelstein, David

AU - Gillison, Maura L.

AU - Pfister, David G.

AU - Spencer, Sharon

AU - Adkins, Douglas

AU - Brizel, David M.

AU - Burtness, Barbara

AU - Busse, Paul M.

AU - Caudell, Jimmy J.

AU - Cmelak, Anthony J.

AU - Colevas, A. Dimitrios

AU - Eisele, David W.

AU - Fenton, Moon

AU - Foote, Robert L.

AU - Gilbert, Jill

AU - Haddad, Robert I.

AU - Hicks, Wesley L.

AU - Hitchcock, Ying J.

AU - Jimeno, Antonio

AU - Leizman, Debra

AU - Lydiatt, William M.

AU - Maghami, Ellie

AU - Mell, Loren K.

AU - Mittal, Bharat B.

AU - Pinto, Harlan A.

AU - Ridge, John A.

AU - Rocco, James

AU - Rodriguez, Cristina P.

AU - Shah, Jatin P.

AU - Weber, Randal S.

AU - Witek, Matthew

AU - Worden, Frank

AU - Yom, Sue S.

AU - Zhen, Weining

AU - Burns, Jennifer L.

AU - Darlow, Susan D.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.

UR - http://www.scopus.com/inward/record.url?scp=85036501504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036501504&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0101

DO - 10.6004/jnccn.2017.0101

M3 - Article

C2 - 28596256

AN - SCOPUS:85036501504

VL - 15

SP - 761

EP - 770

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -